The wide spreads are never the hard part. Any screen comparing price against consensus will throw up names trading 80% or 90% below target, and most of them are artifacts: a single stale estimate, an analyst who stopped updating, coverage thin enough that one opinion becomes the consensus.
This week thirteen candidates came out of the first pass and went straight back in on exactly those grounds. What is left are five names where the gap is backed by enough recent, independent coverage to be worth arguing with. Running FMP's Price Target Summary Bulk API alongside live quotes across the S&P 500 and S&P MidCap 400, this screen ranks by spread and then filters by how many analysts actually contributed to it.
Key Takeaways
- Coverage depth did more filtering than the spread itself: names with two or three targets ever, or none inside the last year, were removed before ranking.
- Three of the five surviving gaps sit in businesses attached to electricity and compute demand, but through completely different mechanisms: motion control, power conversion, and nuclear generation.
- Target dispersion varies sharply across the five. Arrowhead's high and low sit nearly three times apart, while Regal Rexnord's cluster inside a narrow band, which changes what the consensus number means.
- A wide spread indicates disagreement between the market and the analysts covering it. Which side is early is not something the spread itself can answer.
Where Price and Consensus Drifted Furthest Apart
Regal Rexnord (RRX)
Current Price: $148.05 • Consensus Target: $258.20 • Upside Potential: 74.4%
Regal Rexnord carries the widest verified gap in the screen, and it is also the one with the tightest analyst agreement behind it. The high and low targets sit at $286 and $240, a band of less than 20% around a $255 median, which is unusual. Sixteen targets over the past year and four in the last quarter means this is a real consensus rather than one firm's view standing in for several.
What the analysts appear to be modelling is the back half of a deleveraging story. The company took on substantial debt through its acquisition programme and has spent the period since working it down while integrating the automation and motion control businesses. That creates a specific pattern: equity value can compound from debt reduction alone, without needing the operating business to accelerate. It also means the equity carries more sensitivity to any slip in cash generation than the headline multiple suggests.
The balance sheet is therefore the more informative read here than the income statement, and FMP's Balance Sheet Statement API tracks net debt and leverage across the deleveraging path quarter by quarter. Order rates in the industrial powertrain segments, free cash flow conversion, and the pace of debt reduction against stated targets are the disclosures that would confirm or undercut the consensus view.
CAVA Group (CAVA)
Current Price: $51.64 • Consensus Target: $88.89 • Upside Potential: 72.1%
CAVA has the deepest coverage in the group, with 56 targets in the past year and 11 in the last quarter, and it also has the widest disagreement among them: a $58 low against a $106 high. That dispersion is the interesting part. When 56 analysts follow a name and still cannot agree within a factor of nearly two, the argument is structural rather than about the next quarter.
The structural argument is about unit economics at scale. The second quarter delivered roughly 31% revenue growth with comparable sales and traffic ahead of expectations, and full-year guidance was reaffirmed rather than raised. A fast-casual concept expanding its footprint quickly faces a well-worn question: whether new restaurants open at the same productivity as the existing base, or whether the average comes down as the best locations are used up. The low targets assume the latter; the high targets assume the former.
That makes the growth series more decisive than any single quarter, and FMP's Financial Statement Growth API holds the revenue, margin and cash flow growth lines in the comparable form needed to see whether the trajectory is flattening. New restaurant volumes relative to the fleet average, restaurant-level margin, and the split between traffic and pricing inside the comparable sales number are where the disagreement resolves.
Advanced Energy Industries (AEIS)
Current Price: $262.20 • Consensus Target: $436.75 • Upside Potential: 66.6%
Advanced Energy occupies an unusual position: it supplies precision power conversion into both semiconductor manufacturing equipment and data centre infrastructure, which means two of the strongest capital spending cycles running at once land in the same revenue line. Data centre revenue doubled year over year earlier in 2026, the outlook was raised on the back of it, and a new high-voltage platform aimed at AI rack architectures has been added to the portfolio. Twenty-seven targets over the year with six in the last quarter gives the $436.75 consensus reasonable standing.
The complication is that these two end markets rhyme in sentiment and diverge in timing. Semiconductor equipment spending follows fab construction schedules; data centre power follows hyperscaler deployment schedules. Both are cyclical, neither is synchronised with the other, and a company exposed to both can look like a structural growth story in one period and a cyclical one in the next depending on which cycle is running. The spread may simply reflect the market applying a cyclical multiple where analysts are applying a secular one.
Segment disclosure is what separates the two readings, and FMP's Revenue Product Segmentation API breaks the top line into its constituent end markets so the mix shift is visible rather than inferred. Data centre revenue as a share of total, semiconductor equipment order timing, and gross margin by segment are the figures that show which cycle is doing the work.
Talen Energy (TLN)
Current Price: $292.30 • Consensus Target: $467.90 • Upside Potential: 60.1%
Talen is the cleanest example in this screen of a company whose future revenue is substantially contracted and whose equity still trades at a wide discount to where analysts value it. The long-dated nuclear supply arrangement with a hyperscale counterparty converted a merchant generation asset into something much closer to a contracted one, and the 2026 shift in grid market dynamics has added a second layer to the story. Thirty-one targets in the year and eleven in the last quarter, clustered around a $463.50 median, is genuine coverage.
The gap, then, is not about whether the cash flows exist. It is about how they should be valued. A merchant power producer and a contracted infrastructure asset trade on very different multiples, and Talen is somewhere between the two: partially contracted, still exposed to capacity market outcomes and commodity pricing on the uncontracted portion. Analysts moving toward the infrastructure end of that range would explain most of the spread without requiring any change in the underlying business.
Capital structure is central to that judgement, because contracted cash flows support leverage that merchant cash flows do not. FMP's Enterprise Values API carries the debt, cash and enterprise value series that make the comparison to contracted infrastructure peers meaningful. Contracted versus merchant volume mix, capacity auction outcomes, and the hedge book are the variables that determine which multiple is appropriate.
Arrowhead Pharmaceuticals (ARWR)
Current Price: $66.48 • Consensus Target: $104.43 • Upside Potential: 57.1%
Arrowhead carries the widest target dispersion in the screen, with a $46 low against a $126 high across 24 targets in the past year. That range is characteristic of a company transitioning from clinical development to commercial execution, where the analytical question changes from whether a drug works to how quickly it is adopted. Recent Phase 3 data showed a 78% reduction in pancreatitis events for its lead RNAi therapeutic, and a breakthrough therapy designation in severe hypertriglyceridemia sits alongside an early commercial launch and a broadening dual-target pipeline.
Those two questions are valued very differently, which is why the spread is wide and why the dispersion is wider still. Clinical risk resolves in binary steps. Launch trajectory resolves gradually, in prescription data and reimbursement decisions, and it is far harder to model from outside. The shares trading roughly 20% below their 50-day average while the pipeline news has been constructive suggests the market is weighting the commercial question more heavily than the clinical one.
Forward revenue consensus is where that weighting becomes visible, and FMP's Financial Estimates API carries the quarterly and annual revenue and earnings lines that show how steeply analysts have modelled the ramp. Prescription uptake, payer coverage decisions, cash runway against the launch spend, and progression of the dual-target programmes are what will move those estimates rather than the ratings.
What a Wide Spread Is Actually Measuring
Thirteen names were removed from this week's screen before ranking, and that is the part of the process worth dwelling on. A consensus target is an average of opinions, and averages behave badly when the sample is small. One name showed a consensus roughly double its own all-time average target on the strength of a single recent estimate. Another had two targets in total, neither inside the past year, and a spread near 90% that meant nothing at all. The spread is not the signal. The spread divided by the number of people who actually contributed to it is closer to one.
Once that filter is applied, the five survivors say something more specific than "the market is wrong." Regal Rexnord's targets cluster tightly, which means the disagreement is between analysts as a group and the market. CAVA's and Arrowhead's are widely dispersed, which means the analysts do not agree with each other either, and the consensus is a midpoint between incompatible views rather than a considered position. Those are different situations and they warrant different treatment. A tight consensus far from price is a bet against the market. A dispersed consensus far from price is an unresolved argument that happens to average out above the current quote.
Building that distinction into a repeatable process means pairing the spread with its structure. The Price Target Consensus API supplies the high, low and median alongside the average, which is what makes dispersion measurable. The Price Target Summary API adds the counts by period, separating recent coverage from historical. The Ratings Snapshot API shows whether the rating distribution corroborates the targets or contradicts them, and a cluster of hold ratings sitting beneath a high consensus target is a common and informative mismatch.
The next question is whether the targets have any support in the numbers. The Financial Estimates API shows whether forward revenue and earnings moved with the targets or stayed put, which separates a genuine model change from a multiple change. The Cash Flow Statement API tests whether the company can fund what analysts are assuming, which matters more for Talen's contracted build and Arrowhead's launch spend than for anything in the ratings data. The Key Metrics TTM API normalises names that otherwise do not compare, which is the only way a motion control manufacturer, a restaurant chain and a biotech sit in the same ranking without distortion. Assembling that view across five datasets is where the coverage breadth available through FMP does real work, because the spread comes from one endpoint and the verdict on it comes from four others.
There is also a history worth consulting. The Historical Stock Grades API shows how a given name's rating profile has moved over time, which supplies the base rate that a point-in-time snapshot cannot. A stock whose targets have been revised down steadily for six quarters and still sits 60% above the price is telling a different story from one where the gap opened in a single month. Neither is a conclusion. Both are considerably more useful than the spread on its own.
Creating a Structured Target-Gap Workflow
A price-target spread only becomes useful when the calculation can be reproduced reliably. That means fixing the data inputs, pulling them in a consistent sequence, and applying the same formula every time the screen runs. Once those elements are standardized, the exercise stops being a one-off comparison and turns into a process that can be refreshed on a schedule.
The only requirement before running the workflow is a valid API key.
Step 1: Pull Analyst Price Targets
The process starts by establishing where consensus currently sits. This is done by querying the Price Target Summary Bulk API, which returns average price targets along with analyst participation counts across the ticker set in a single call. That combination matters: the average target provides the reference level, while coverage depth helps contextualize how representative that number is. Together, they form the baseline against which market prices will be compared.
Endpoint:
|
https://financialmodelingprep.com/stable/price-target-summary-bulk?apikey=YOUR_API_KEY |
Sample Response:
|
[ { "symbol": "AAPL", "lastQuarterCount": "12", "lastQuarterAvgPriceTarget": "228.15", "lastYearAvgPriceTarget": "205.34" } ] |
Step 2: Pull Latest Market Prices
Once targets are in place, the next input is the current trading price. This comes from the Company Profile Data API, which includes the most recent quote used for comparison. At this stage, the goal isn't granularity or intraday precision — it's simply to anchor each name to the same market reference point so gaps are calculated consistently.
|
https://financialmodelingprep.com/stable/profile/AAPL?apikey=YOUR_API_KEY |
Step 3: Derive the Target Gap
Once both values are available, the gap itself is straightforward to compute. Express it as a percentage to normalize results across different price levels:
Upside % = (Price Target - Current Price) / Current Price × 100
Using percentages allows large-cap and lower-priced names to sit in the same ranking without distortion.
Step 4: Apply a Threshold Filter
The final layer is judgment. Most workflows introduce a minimum threshold — often around 20% — to filter out routine variance and focus attention on gaps that are large enough to matter. At this stage, analyst coverage becomes part of the interpretation: a wide gap backed by broad, recent coverage carries a different weight than one driven by a small or outdated estimate set.
Structured this way, the process moves beyond a simple valuation screen. It becomes a repeatable diagnostic tool — one that highlights where price and consensus are drifting apart and does so in a way that can be refreshed, audited, and scaled across time and coverage universes.
From Individual Screen to Institutional Research Process
Most quantitative workflows begin quietly — a model or screen built by a single analyst to answer a recurring question with greater consistency. The first version usually lives in a spreadsheet or a small script: efficient, practical, and tailored to the needs of one desk. The turning point arrives when the signal proves useful enough that colleagues begin asking for it. Replication follows, and with it comes an unintended side effect: slight variations in endpoints, refresh schedules, or calculation logic start producing subtly different results.
At that stage, the analyst who created the workflow often becomes an informal architect of standardization. The challenge shifts from running the screen to defining the method behind it. Institutional value emerges when the process is formalized: the data sources are fixed, the sequence of API pulls is documented, formulas are locked, and thresholds are explicitly defined. Once those elements are stabilized, the workflow stops being a personal tool and begins to function as a shared research input.
Moving the process into a centralized dashboard with scheduled updates is usually the next step in that evolution. Instead of circulating spreadsheets or ad-hoc scripts, teams interact with the same data pipeline and the same calculation framework. This reduces workflow fragmentation across research groups and allows portfolio managers, analysts, and risk teams to reference the same signal simultaneously. When everyone is drawing from the same dataset and methodology, discussions shift away from reconciling numbers and toward interpreting what the signal actually means.
Standardization also strengthens governance and transparency. A centralized workflow creates a visible audit trail: where the data originated, when it refreshed, and how each metric was derived. That lineage matters in institutional environments where reproducibility is essential. When colleagues run the same query and obtain the same result, the signal becomes dependable infrastructure rather than a one-off analytical shortcut.
Scaling that kind of workflow across a team requires stable access to the underlying datasets and consistent distribution across users. Infrastructure becomes less about adding features and more about removing friction from the research process. Platforms designed for institutional usage — such as FMP's Enterprise plan — provide the access controls, refresh stability, and shared environment needed when a desk-level workflow transitions into a broader research tool.
When that transition happens successfully, the model itself changes role. The target-gap screen is no longer simply a clever comparison between price and analyst targets. It becomes part of the firm's analytical framework — a standardized diagnostic that multiple teams can rely on to identify where market pricing and consensus expectations are beginning to drift apart.
When the Market Moves Before the Models Do
Five gaps that survived a coverage filter are worth more than fifty that did not, and the value of running FMP's Price Target Summary Bulk API on a schedule is that the same test gets applied every week rather than when someone remembers to apply it. The spread flags the disagreement. Everything after that is reading it properly.
If you enjoyed this analysis, you'll also want to read: Weekly Signals Desk | Five Notable Valuation Disconnects from the FMP API (Sept 7-11)
Disclosure: Signals Desk content is provided for informational and analytical purposes only and does not constitute investment advice or trade recommendations. The analysis reflects interpretation of market data and publicly disclosed or third-party information, including data accessed via Financial Modeling Prep APIs, at the time of publication. Signals discussed are probabilistic, can be wrong, and may change as market conditions and consensus data evolve. This content should be considered alongside broader research, individual objectives, and risk assessment.
